Kiromic Biopharma, Inc.·4

Aug 15, 4:31 PM ET

Dahlbeck Scott 4

4 · Kiromic Biopharma, Inc. · Filed Aug 15, 2022

Insider Transaction Report

Form 4
Period: 2022-08-11
Dahlbeck Scott
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-08-11+50,000496,757 total
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs vested on August 11, 2022.
  • [F2]Includes (i) 50,000 shares of common stock underlying the RSUs and (ii) 446,757 shares of common stock.

Documents

1 file
  • 4
    tm2223481-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT